Short Interest in CSL Limited (OTCMKTS:CSLLY) Increases By 3,400.0%

CSL Limited (OTCMKTS:CSLLY) saw a large growth in short interest in the month of October. As of October 31st, there was short interest totalling 17,500 shares, a growth of 3,400.0% from the October 15th total of 500 shares. Based on an average daily trading volume, of 52,300 shares, the days-to-cover ratio is presently 0.3 days.

Wall Street Analysts Forecast Growth

Separately, Macquarie upgraded shares of CSL to a “strong-buy” rating in a research report on Tuesday, August 13th.

CSL Trading Down 1.7 %

Shares of CSLLY stock opened at $92.90 on Wednesday. The firm has a 50-day moving average price of $98.59 and a 200 day moving average price of $98.30. CSL has a twelve month low of $79.95 and a twelve month high of $109.00. The company has a debt-to-equity ratio of 0.58, a current ratio of 2.18 and a quick ratio of 0.97.

CSL Company Profile

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants.